Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Neogenomics Inc (NEO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Neogenomics Inc 12701 COMMONWEALTH DRIVE SUITE 9 FORT MYERS FL 33913 USA

P: 239-768-0600

Description:

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs in Nashville, TN, Irvine, CA and Fort Myers and services the needs of pathologists, oncologists, urologists, hospitals and other reference laboratories throughout the United States.

Key Statistics

Overview:

Market Capitalization, $K 1,889,429
Shares Outstanding, K 94,566
Annual Sales, $ 276,740 K
Annual Net Income, $ 2,640 K
Last Quarter Sales, $ 76,480 K
Last Quarter Net Income, $ 350 K
60-Month Beta 0.93
% of Insider Shareholders 12.20%
% of Institutional Shareholders 76.89%
Float, K 83,029
% Float 87.80%

Growth:

1-Year Return 115.95%
3-Year Return 147.79%
5-Year Return 518.71%
5-Year Revenue Growth 316.34%
5-Year Earnings Growth 225.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.06 on 02/19/19
Next Earnings Date 04/30/19
Earnings Per Share ttm 0.13
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 0.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

NEO Ratios

Ratio
Price/Earnings ttm 151.23
Price/Earnings forward 176.39
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) 2.25
Return-on-Assets (Before Tax) 1.31
Profit Margin % 0.95
Net Margin % N/A
Debt/Equity 0.31
Price/Sales 6.72
Price/Cash Flow 60.78
Price/Book 5.73
Book Value/Share 3.43
Interest Coverage -1.61
Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar